Atlas Trials

Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

Clinical trial NCT01054781 · COMPLETED

Trial details

NCT number
NCT01054781
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma (DLBCL)
Start date
2009-01-01
Primary completion
2010-11-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.